Transparent reporting of recruitment and informed consent approaches in clinical trials recruiting children with minor parents in sub-Saharan Africa: a secondary analysis based on a systematic review.
Children
Clinical trials
Informed consent
Minor parents
Reporting
Sub-Saharan Africa
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
28 07 2021
28 07 2021
Historique:
received:
08
10
2020
accepted:
18
05
2021
entrez:
29
7
2021
pubmed:
30
7
2021
medline:
6
8
2021
Statut:
epublish
Résumé
Standardised checklists of items to be addressed in clinical study protocols and publications are promoting transparency in research. However, particular specifications for exceptional cases, such as children with minor parents are missing. This study aimed to examine the level of transparency regarding recruitment and informed consent approaches in publications of clinical trials recruiting children with minor parents in sub-Saharan Africa. We thereby focused particularly on the transparency about consenting persons (i.e. proxy decision-makers) and assessed the need to expand reporting guidelines for such exceptional cases. We conducted a secondary analysis of clinical trial publications previously identified through a systematic review. Multiple scientific databases were searched up to March 2019. Clinical trial publications addressing consent and potentially recruiting children with minor parents in sub-Saharan Africa were included. 44 of the in total 4382 screened articles met our inclusion criteria. A descriptive analysis was performed. None of the included articles provided full evidence on whether any recruited children had minor parents and how consent was obtained for them. Four proxy decision-maker types were identified (parents; parents or guardians; guardians; or caregivers), with further descriptions provided rarely and mostly in referenced clinical trial registrations or protocols. Also, terminology describing proxy decision-makers was often used inconsistently. Reporting the minimum maternal age alongside maternal data provided in baseline demographics can increase transparency on the recruitment of children with minor mothers. The CONSORT checklist should require clinical trial publications to state or reference exceptional informed consent procedures applied for special population groups. A standardized definition of proxy decision-maker types in international clinical trial guidelines would facilitate correct and transparent informed consent for children and children with minor parents. CRD42018074220 .
Sections du résumé
BACKGROUND
Standardised checklists of items to be addressed in clinical study protocols and publications are promoting transparency in research. However, particular specifications for exceptional cases, such as children with minor parents are missing. This study aimed to examine the level of transparency regarding recruitment and informed consent approaches in publications of clinical trials recruiting children with minor parents in sub-Saharan Africa. We thereby focused particularly on the transparency about consenting persons (i.e. proxy decision-makers) and assessed the need to expand reporting guidelines for such exceptional cases.
METHODS
We conducted a secondary analysis of clinical trial publications previously identified through a systematic review. Multiple scientific databases were searched up to March 2019. Clinical trial publications addressing consent and potentially recruiting children with minor parents in sub-Saharan Africa were included. 44 of the in total 4382 screened articles met our inclusion criteria. A descriptive analysis was performed.
RESULTS
None of the included articles provided full evidence on whether any recruited children had minor parents and how consent was obtained for them. Four proxy decision-maker types were identified (parents; parents or guardians; guardians; or caregivers), with further descriptions provided rarely and mostly in referenced clinical trial registrations or protocols. Also, terminology describing proxy decision-makers was often used inconsistently.
CONCLUSIONS
Reporting the minimum maternal age alongside maternal data provided in baseline demographics can increase transparency on the recruitment of children with minor mothers. The CONSORT checklist should require clinical trial publications to state or reference exceptional informed consent procedures applied for special population groups. A standardized definition of proxy decision-maker types in international clinical trial guidelines would facilitate correct and transparent informed consent for children and children with minor parents.
STUDY REGISTRATION
CRD42018074220 .
Identifiants
pubmed: 34320934
doi: 10.1186/s12889-021-11079-y
pii: 10.1186/s12889-021-11079-y
pmc: PMC8318049
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1473Informations de copyright
© 2021. The Author(s).
Références
J Infect Dis. 2013 Aug 1;208(3):423-31
pubmed: 23599316
BMC Med. 2010 Mar 24;8:18
pubmed: 20334633
BMC Infect Dis. 2014 Apr 22;14:216
pubmed: 24755001
Acta Trop. 2005 Sep;95(3):194-203
pubmed: 16054584
J Med Ethics. 2005 May;31(5):251-5
pubmed: 15863678
Trials. 2015 Sep 18;16:417
pubmed: 26385379
J Clin Epidemiol. 2020 Jan;117:151-153
pubmed: 31542506
Paediatr Drugs. 2018 Jun;20(3):215-222
pubmed: 29476333
Syst Rev. 2012 Nov 29;1:60
pubmed: 23194585
Lancet. 2018 Nov 10;392(10159):1736-1788
pubmed: 30496103
Lancet. 2007 Mar 17;369(9565):927-34
pubmed: 17368154
J Infect Dis. 2014 Aug 15;210(4):585-92
pubmed: 24652498
JAMA. 2002 Jun 5;287(21):2835-8
pubmed: 12038927
Malar J. 2010 Nov 21;9:332
pubmed: 21092137
Trop Med Int Health. 1996 Apr;1(2):231-5
pubmed: 8665390
Lancet. 2018 Nov 10;392(10159):1684-1735
pubmed: 30496102
J Okla State Med Assoc. 2018 Oct;111(8):776-783
pubmed: 31379392
N Engl J Med. 1990 Jul 19;323(3):160-4
pubmed: 2194128
Malar J. 2010 Nov 22;9:335
pubmed: 21092220
Malar J. 2015 Oct 31;14:429
pubmed: 26520401
PLoS One. 2015 Mar 27;10(3):e0122242
pubmed: 25816354
JAMA Ophthalmol. 2013 Apr;131(4):431-6
pubmed: 23392481
Lancet. 2016 Jun 11;387(10036):2423-78
pubmed: 27174304
PLoS Negl Trop Dis. 2010 Jun 29;4(6):e619
pubmed: 20614013
BMC Med Ethics. 2019 Dec 5;20(1):94
pubmed: 31805918
Lancet. 2002 Nov 2;360(9343):1375-80
pubmed: 12423984
J Infect Dis. 2012 Jan 15;205(2):228-36
pubmed: 22158680
Pediatrics. 2012 Nov;130(5):e1269-77
pubmed: 23027172
Vaccine. 2012 Apr 27;30 Suppl 1:A44-51
pubmed: 22520136
Lancet. 2014 Jan 18;383(9913):257-66
pubmed: 24411650
Lancet. 2010 Jul 24;376(9737):229-30
pubmed: 20656114
PLoS Med. 2011 Oct;8(10):e1001107
pubmed: 22028630
Pediatr Infect Dis J. 2011 Apr;30(4):e68-74
pubmed: 21289531
Lancet. 2001 May 12;357(9267):1471-7
pubmed: 11377597
Arch Pediatr Adolesc Med. 2008 Jul;162(7):619-26
pubmed: 18606932
Malar J. 2006 May 16;5:43
pubmed: 16704735
BMC Med Ethics. 2012 Jul 20;13:17
pubmed: 22818109
Antivir Ther. 2010;15(1):83-90
pubmed: 20167994
Matern Child Nutr. 2015 Dec;11 Suppl 4:132-43
pubmed: 23795976
Am J Clin Nutr. 2002 Oct;76(4):805-12
pubmed: 12324294
Am J Hematol. 1999 Sep;62(1):1-6
pubmed: 10467269
N Engl J Med. 2017 Mar 23;376(12):1121-1130
pubmed: 28328346
Int J Surg. 2012;10(1):28-55
pubmed: 22036893
Am J Clin Nutr. 2015 Feb;101(2):387-97
pubmed: 25646337
Malar J. 2015 Jan 28;14:27
pubmed: 25626448
Pediatr Infect Dis J. 2000 May;19(5):405-10
pubmed: 10819335
J Empir Res Hum Res Ethics. 2011 Sep;6(3):93-7
pubmed: 21931242
PLoS Med. 2016 Mar 01;13(3):e1001967
pubmed: 26930627
PLoS One. 2020 Aug 4;15(8):e0237088
pubmed: 32750084
Matern Child Nutr. 2017 Jul;13(3):
pubmed: 27910260
Vaccine. 2012 Apr 27;30 Suppl 1:A71-8
pubmed: 22520140
J Family Med Prim Care. 2013 Apr;2(2):153-8
pubmed: 24479070
Trials. 2011 Jun 04;12:138
pubmed: 21639927
Pediatrics. 2016 Aug;138(2):
pubmed: 27456514
Matern Child Nutr. 2006 Jul;2(3):169-80
pubmed: 16881929
Ann Intern Med. 2013 Feb 5;158(3):200-7
pubmed: 23295957
Lancet. 2010 Aug 21;376(9741):606-14
pubmed: 20692030
Iowa Orthop J. 2010;30:7-14
pubmed: 21045965
Lancet Haematol. 2015 Mar;2(3):e101-7
pubmed: 26687795
Malar J. 2016 Jan 08;15:16
pubmed: 26743431
Malar J. 2011 Mar 16;10:64
pubmed: 21410954
PLoS One. 2012;7(11):e49143
pubmed: 23185303
BMJ Paediatr Open. 2018 Nov 26;2(1):e000369
pubmed: 30555937
N Engl J Med. 1997 Jan 30;336(5):370-3
pubmed: 9011793
Obstet Gynecol. 2009 Dec;114(6):1341-1345
pubmed: 19935040
J Clin Epidemiol. 2020 Jan;117:150-151
pubmed: 31542507
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
PLoS One. 2013 Oct 24;8(10):e78289
pubmed: 24205185
Pediatr Blood Cancer. 2005 Mar;44(3):245-50
pubmed: 15547922